Carrier systems for the local delivery of antibiotics in bone infections.
about
Clinical Application of Antimicrobial Bone Graft Substitute in Osteomyelitis Treatment: A Systematic Review of Different Bone Graft Substitutes Available in Clinical Treatment of OsteomyelitisNanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisEfficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsAntibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cementComparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis modelComparison of various surgical methods in the treatment of implant-related infectionVancomycin displays time-dependent eradication of mature Staphylococcus aureus biofilms.Antimicrobial functionalized genetically engineered spider silk.Biodegradable vancomycin-eluting poly[(d,l)-lactide-co-glycolide] nanofibres for the treatment of postoperative central nervous system infection.A resorbable antibiotic-eluting polymer composite bone void filler for perioperative infection prevention in a rabbit radial defect modelVancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study.Immobilized antibiotics to prevent orthopaedic implant infections.Injectable gellan gum-based nanoparticles-loaded system for the local delivery of vancomycin in osteomyelitis treatment.Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacinA new type of biphasic calcium phosphate cement as a gentamicin carrier for osteomyelitis.Influence of third-body particles originating from bone void fillers on the wear of ultra-high-molecular-weight polyethylene.Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studies.Dual delivery of an antibiotic and a growth factor addresses both the microbiological and biological challenges of contaminated bone fractures.Coatings and surface modifications imparting antimicrobial activity to orthopedic implants.Local antibiotic delivery systems in diabetic foot osteomyelitis: time for one step beyond?Nanofibers used for delivery of antimicrobial agents.Vancomycin containing PLLA/β-TCP controls MRSA in vitro.Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control.Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.Insights on the properties of levofloxacin-adsorbed Sr- and Mg-doped calcium phosphate powders.In vitro antibacterial efficacy of tetracycline hydrochloride adsorbed onto Bio-Oss bone graft.Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.Orthopaedic biofilm infections.Risk Factors Associated With Survival to Hospital Discharge of 54 Horses With Fractures of the Radius.Polymer-controlled release of tobramycin from bone graft void filler.Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.Ciprofloxacin monoolein water gels as implants for the treatment of chronic osteomyelitis: In vitro characterization.A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis.Cis-2-decenoic acid inhibits S. aureus growth and biofilm in vitro: a pilot study.Increased release time of antibiotics from bone allografts through a novel biodegradable coating.Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.In vitro elution of daptomycin by a synthetic crystallic semihydrate form of calcium sulfate, stimulan.Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds.Identification of the enzymatic active site of tobacco caffeoyl-coenzyme A O-methyltransferase by site-directed mutagenesis.
P2860
Q26767155-4F5BB103-29D0-4F6E-88BD-F2189DC9E30EQ28086953-75890B82-D61A-49E7-A62F-E844E2DBAC8AQ33721979-E332E20F-5BDF-46B8-B4E5-B17A87DFB6A2Q33742858-DE3B9270-C858-4FA6-A167-028D21F80E3BQ33759744-4E281556-B502-4C7A-AC02-5C83C7894B25Q33836485-4C59AA47-1A10-48FF-AD1B-1F6D166DA603Q33971619-8FEBAB57-A135-4BEB-A74D-BE53C5D33A5FQ34526414-3116255C-E63B-46B4-AA86-84DF0F95040AQ34851126-C4E1279F-4A2E-4E0E-993C-E09147C34F0FQ34981072-13E0D04E-06A6-48ED-AA07-25D45F29D727Q35225221-0EC5A544-C71C-4219-B673-0A01E99E19A0Q36106178-C5BE8727-E0F3-4002-A461-760F8B911C3CQ36146837-888F2863-B6A8-4C93-8A1C-A137E1DC8845Q36337406-9A6F259B-0E3B-4C1D-B604-4B9621191ED8Q36744859-DE14782A-7BE1-4C2D-9D5E-FE643013834EQ36801819-B04A5C0D-5435-4BE2-948B-7AC4875E0D2BQ37111300-9B9B40EE-D055-464F-B455-0DC4E389D369Q37186168-6473C52F-4ED6-4DC2-9B4D-463778ED60DBQ37948149-A9BCAFE2-07E0-491A-9C8F-4FAB8FCD06B9Q38215477-64F5CAF0-45DB-4148-B497-29B97A2A15B9Q38325417-874E7B8C-B60B-4322-A4E6-47F01351E772Q38542278-655C2D27-DA56-4AAF-B82A-4D4BAD9FA180Q38592902-D107A20B-085E-4012-AB21-046701108F9BQ39635668-1A441E59-AC92-4DA6-9B4B-AD18768FF7EAQ39656622-DC73647C-DE7D-4221-80DD-56DEAF7F71D5Q39684601-BADA07CE-8912-4F11-B086-97EE066E31B6Q39745588-DEF87F59-3106-4D52-A776-62DC942F03A7Q40211387-9C513FFA-634C-442A-8992-64662C903051Q40252041-99C359BE-9B2D-44CB-B8FD-8627FE77083DQ40957907-3352255E-D404-4EF1-B113-05285ABAF304Q41197707-FC637EEE-657D-4A41-9417-83F798A7162BQ41586328-21B667C4-B639-42E5-A18E-E36C562A9632Q41833727-DC9A5C3A-DDC5-48C6-A4C8-320A2C1701FCQ41864671-3074D20C-876F-49D7-979C-28908C549312Q42325198-52DF8DBB-8D41-48DC-81F2-DAFC0F42E6B3Q42728428-656B6B06-139D-4395-9F94-1D9984A07FE9Q42829153-FA1BEFEA-726B-48D0-9BF9-B08824BF252DQ43102631-219127E0-B4A6-492D-98D4-3C45A5D77C20Q43205465-8EFD8F79-0FD5-453F-90E0-91C14BC41C9EQ43680030-356418A2-23AA-402F-A7DE-B96B1B6AF1DD
P2860
Carrier systems for the local delivery of antibiotics in bone infections.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Carrier systems for the local delivery of antibiotics in bone infections.
@ast
Carrier systems for the local delivery of antibiotics in bone infections.
@en
type
label
Carrier systems for the local delivery of antibiotics in bone infections.
@ast
Carrier systems for the local delivery of antibiotics in bone infections.
@en
prefLabel
Carrier systems for the local delivery of antibiotics in bone infections.
@ast
Carrier systems for the local delivery of antibiotics in bone infections.
@en
P1433
P1476
Carrier systems for the local delivery of antibiotics in bone infections.
@en
P2093
Giamarellos-Bourboulis EJ
Kanellakopoulou K
P304
P356
10.2165/00003495-200059060-00003
P577
2000-06-01T00:00:00Z
P6179
1045814791